A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis.

1974 
AbstractA short-term double-blind controlled trial of a new anti-inflammatory drug DA 2370 (prenazone) was carried out on 24 patients with rheumatoid arthritis. Under the conditions of the trial this compound exhibited antirheumatic activity of the same order of magnitude as indomethacin. Side-effects were few and relatively mild.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    10
    References
    9
    Citations
    NaN
    KQI
    []